Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy

Rheumatology (Oxford). 2014 May;53(5):957-8. doi: 10.1093/rheumatology/ket361. Epub 2013 Nov 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • B-Cell Activating Factor / drug effects
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / pathology*
  • Cell Proliferation / drug effects
  • Cryoglobulins / metabolism*
  • Female
  • Humans
  • Injections, Subcutaneous
  • Lupus Erythematosus, Systemic / blood*
  • Lupus Erythematosus, Systemic / drug therapy*
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / pharmacology
  • Recombinant Fusion Proteins / therapeutic use*
  • Treatment Outcome

Substances

  • AMG623 peptibody
  • B-Cell Activating Factor
  • Cryoglobulins
  • Recombinant Fusion Proteins
  • TNFSF13B protein, human